SCHEMBL297196

SCHEMBL297196

Cc1ccccc1C[N]Cc1ccccc1C

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.52
ACHE P22303 2/20 0.47
TSHR P16473 1/20 0.47
CTBP2 P56545 1/20 0.44
CHRM2 P08172 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
KMT2A Q03164 1/20 0.42
CYP2A13 Q16696 1/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
ACAT2 Q9BWD1 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3482967 0.84 TAAR1 (0.48) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL14616181 0.82 TAAR1 (0.46) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL15304790 0.82 TAAR1 (0.46) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL6582 0.79 TAAR1 (0.43) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL2564569 0.77 MIF (0.52) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL8244140 0.77 TAAR1 (0.42) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL2090458 0.77 TAAR1 (0.56) TAAR1ACHETSHRCHRM2PTGS1
SCHEMBL29477327 0.77 TAAR1 (0.56) TAAR1ACHETSHRCHRM2PTGS1
SCHEMBL143962 0.77 TAAR1 (0.71) TAAR1ACHETSHRCTBP2CHRM2
SCHEMBL40576 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700628-B2 Aromatic ether derivatives useful as thrombin inhibitors ELI LILLY AND COMPANY (US) 2010-04-20 US claimed
EP-1817287-B1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS LILLY CO ELI (US) 2010-02-10 EP claimed
US-20090227566-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS ELI LILLY AND COMPANY 2009-09-10 US claimed
EP-1817287-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS Eli Lilly and Company (US) 2007-08-15 EP claimed
WO-2006057845-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS ELI LILLY AND COMPANY (US) 2006-06-01 WO claimed
US-20240198316-A1 SYNTHETIC POLYMERIC POROUS MEDIUM WITH HIERARCHICAL MULTIPLE LAYER STRUCTURE, ITS DESIGN, SYNTHESIS, MODIFICATION, AND LIQUID CHROMATOGRAPHIC APPLICATIONS SUZHOU SEPAX TECHNOLOGIES, INC. (CN) 2024-06-20 US disclosed
EP-1583567-B1 Bacteria trapping wiping tissue SCA HYGIENE PROD AB (SE) 2012-03-14 EP disclosed
US-7947292-B2 Bacteria trapping fibrous material SCA HYGIENE PRODUCTS AB (SE) 2011-05-24 US disclosed
US-20100278690-A1 Bacteria trapping fibrous material SCA HYGIENE PRODUCTS AB (SE) 2010-11-04 US disclosed
US-7700628-B2 Aromatic ether derivatives useful as thrombin inhibitors ELI LILLY AND COMPANY (US) 2010-04-20 US disclosed
EP-1817287-B1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS LILLY CO ELI (US) 2010-02-10 EP disclosed
US-20090227566-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS ELI LILLY AND COMPANY 2009-09-10 US disclosed
US-5889081-A POLYCARBOSILANE OSAKA GAS COMPANY LIMITED (JP) 1999-03-30 US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 EP disclosed
US-5233089-A Charge transport material; used in electrophotographic plates to provide improved sensitivity, photoresponse and durability HITACHI, LTD. (JP) 1993-08-03 US disclosed
EP-0273426-A2 Enamine derivatives, production thereof and electrophotographic plates containing the same Hitachi Chemical Co., Ltd. (JP) 1988-07-06 EP disclosed
US-4491663-A TRIMERIZATION TO FORM ISOCYANURATE FORD MOTOR COMPANY (US) 1985-01-01 US disclosed
US-4486556-A CORROSION RESISTANT, AUTOMOBILES AND APPLIANCES FORD MOTOR COMPANY (US) 1984-12-04 US disclosed
US-3998841-A CHLOROTHIO-N-PHTHALIMIDE AND PROCESS THEREFOR BAYER AKTIENGESELLSCHAFT (DT) 1976-12-21 US disclosed
US-3962527-A Novel polymers and photographic elements containing same EASTMAN KODAK COMPANY (US) 1976-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227566-A1 AROMATIC ETHER DERIVATIVES USEFUL AS THROMBIN INHIBITORS TFPI, F2, F11 TAAR1 2327/4885ACHE 1035/4885TSHR 975/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.